Biotech and Pharmaceuticals Pharmaceuticals

More

  • TRENTON, N.J.— Pfizer is fortifying its key immunology and inflammation drug business, snapping up a small maker of skin disorder treatments for about $5.2 billion, weeks after the U.S. Treasury Department torpedoed Pfizer's planned $160 billion deal for Allergan PLC. Pfizer Inc.' s agreement Monday to acquire Anacor Pharmaceuticals Inc., a money-losing...

  • HONG KONG, May 16- Shanghai Fosun Pharmaceutical Co has made a non-binding proposal to buy India's Gland Pharma, which is backed by KKR and valued at up to $1.5 billion, to boost its drug manufacturing and research and development capacity. The move is also a departure from the group's strategy of largely targeting companies in developed markets and comes after...

  • Young boy checked up by the doctor

    Spending on children's health care grew annually by an average of 5.1 percent from 2010 to 2014, mainly due to price hikes.

  • HONG KONG, May 16- Shanghai Fosun Pharmaceutical Co Ltd said on Monday it has made a non-binding proposal for KKR-backed Gland Pharma Ltd, a move that would improve its drug manufacturing and research and development capacity. Gland Pharma founders and KKR, which jointly own about 96 percent of the Hyderabad- based injectable drugs manufacturer, are selling...

  • NEW YORK, May 13- Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest U.S. drugmaker said on Friday. "We are enforcing a distribution restriction for specific products that have been part of, or considered by some states for, their lethal injection protocols," the New York- based drugmaker said on its website.

  • BERLIN, May 13- The firm that invented thalidomide, a drug that caused birth defects in thousands of babies, carried out a deliberate disinformation campaign when experts first spotted possible severe side effects, a report commissioned by the German state of North-Rhine Westphalia said on Friday. It was sold under the name Contergan in Germany, and elsewhere...

  • May 13- France's Sanofi SA was moving ahead on Friday with preparations to replace Medivation Inc's board of directors after the U.S. cancer drug maker refused to engage with it in sale talks based on a $9.3 billion acquisition offer. However, Medivation will not engage in sale talks with Sanofi unless the latter raises its $52.50 per share cash offer, the people...

  • May 13- Drugmaker Mylan NV said it would buy Renaissance Acquisition Holdings LLC's non-sterile, topicals-focused specialty and generics business for $950 million. The deal will add about 25 branded and generic topical products, the company said on Friday. The deal, which is expected to close by the end of the third quarter, includes additional contingent...

  • NEW DELHI, May 13- India announced a new intellectual property policy on Friday, speeding up the online registration of patents and trademarks, but resisted pressure from the United States and other Western countries to amend its patent laws. Since Prime Minister Narendra Modi took office in 2014, global drug brands led by U.S. companies have been pushing for...

  • A weaker pound would not be good: Novo Nordisk CEO

    Lars Sorensen, CEO of Novo Nordisk, shares what he thinks of a potential Brexit by the U.K. in next month's referendum and how it would hit the currency.

  • Falls upends

    Shares of Valeant fell nearly 6 percent after the New York Times reported the company has not kept the discount promises it made to Congress.

  • *One-time hit from Venezuela business of 4.31 bln rupees. MUMBAI, May 12- India's second largest drugmaker Dr Reddy's Laboratories Ltd is bracing for another challenging year in its biggest market, the United States, where its business has been hurt by regulatory scrutiny and fewer new drug approvals. The company is working on bringing three of its key...

  • Tylenol could do more than relieve pain

    Researchers claim acetaminophen, the active ingredient in the medicine can decrease empathy.

  • A pedestrian walks past an elderly woman begging for money.

    The study said when people took acetaminophen, Tylenol's main ingredient, they were less likely to empathize with people experiencing pain. The USAToday reports.

  • Majority of Americans want to ban TV drug ads

    More than half of respondents say they would support removing prescription drug advertisements from TV.

  • Bill Ackman parting ways with Bill Doyle

    Doyle is the man believed to be behind Pershing Square's controversial investment in Valeant Pharmaceuticals.

  • Bill Ackman, founder and chief executive officer of Pershing Square Capital Management LP

    Hedge fund manager Bill Ackman is parting company with the man who introduced him to his bad investment in Valeant Pharmaceuticals.

  • LAS VEGAS, May 11- William Doyle, a key figure in Pershing Square Capital Management's controversial investment in battered drug company Valeant Pharmaceuticals, is leaving the hedge fund, its founder, William Ackman, told investors on Wednesday. Doyle introduced Michael Pearson, the former CEO of Valeant, and Ackman, the billionaire activist investor, in early...

  • LAS VEGAS, May 11- William Doyle, a key figure in Pershing Square Capital Management's controversial investment in battered drug company Valeant Pharmaceuticals, is leaving the hedge fund, its founder, William Ackman, told investors on Wednesday.

  • Changing the channel with the remote

    There is also strong opposition to speeding up the federal drug approval process, a new poll finds.